Campbell & Co Investment Adviser’s MiMedx Group MDXG Stock Holding History

Campbell & Co Investment Adviser’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-14,203	Closed	-$56.1K	–	1224
2026 Q1	$56.1K	Buy	+14,203	New	+$71.5K	﹤0.01%	1012
2025 Q4	–	Sell	-32,966	Closed	-$230K	–	1293
2025 Q3	$230K	Sell	32,966 -792	-2%	-$5.5K	0.02%	979
2025 Q2	$206K	Sell	33,758 -41,185	-55%	-$274K	0.01%	1052
2025 Q1	$570K	Sell	74,943 -28,800	-28%	-$241K	0.04%	625
2024 Q4	$998K	Sell	103,743 -20,302	-16%	-$158K	0.08%	397
2024 Q3	$733K	Sell	124,045 -64,199	-34%	-$425K	0.05%	559
2024 Q2	$1.3M	Buy	188,244 +42,135	+29%	+$296K	0.11%	270
2024 Q1	$1.13M	Sell	146,109 -115,495	-44%	-$928K	0.1%	349
2023 Q4	$2.29M	Buy	261,604 +55,435	+27%	+$406K	0.21%	101
2023 Q3	$1.5M	Buy	206,169 +145,287	+239%	+$1.08M	0.18%	155
2023 Q2	$402K	Buy	+60,882	New	+$310K	0.07%	526

Other funds holding MDXG

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Campbell & Co Investment Adviser's MDXG Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of MiMedx Group (MDXG) in Q2 2026, closing a stake of 14,203 shares — an estimated $56.1K sold.

Campbell & Co Investment Adviser first reported a position in MDXG in Q2 2023 and held it in 11 quarters. The position peaked at $2.29M in Q4 2023. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

Campbell & Co Investment Adviser reported no remaining MiMedx Group position as of Q2 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 14,203 MiMedx Group shares in Q2 2026, an estimated $56.1K.
Campbell & Co Investment Adviser first reported a position in MiMedx Group in Q2 2023 and held it in 11 quarters.
Campbell & Co Investment Adviser's MiMedx Group position peaked at $2.29M in Q4 2023.
227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.